BioNTech SE - BNTX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | Medine GmbH | 15.5% | 39,218,111 | View |
| May 15, 2026 | SCHEDULE 13G/A | Ugur Sahin | 15.8% | 40,076,320 | View |
| May 14, 2026 | SCHEDULE 13G/A | ATHOS KG | 40.2% | 101,702,378 | View |
| May 14, 2026 | SCHEDULE 13G/A | AT Impf GmbH | 40.2% | 101,702,378 | View |
| May 14, 2026 | SCHEDULE 13G/A | Thomas Maier | 40.2% | 101,702,378 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.